Author

P. Shah

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 8 Microbiology· 5 Biochemistry· 3 Bioengineering· 3 Cell Biology· 3 Evolutionary Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 24 Organism:human· 14 Research Focus:cell type annotation· 8 Research Focus:differential expression· 6 Research Focus:drug response / drug discovery· 6 Organism:mouse· 6 Assay:proteomics· 6 Approach:statistical model· 6

Frequent Co-Authors

J. Lammerding· 4 shared X. Xu· 4 shared A. Jadhav· 2 shared A. Simeonov· 2 shared B. E. Nickels· 2 shared D. M. Taylor· 2 shared I. O. Vvedenskaya· 2 shared J. S. Favate· 2 shared

Activity by Year

2017-2023 · peak 7/yr

Co-Author Collaboration Network

10 top collaborators · 14 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersCancer Biology

J. Lammerding

Author profile →

31 papers

Recent·Most cited

Cancer BiologybioRxivApr 7, 2017

Assessing Inhibitors Of Mutant Isocitrate Dehydrogenase Using A Suite Of Pre-Clinical Discovery Assays

D. J. Urban, N. J. Martinez, M. I. Davis…·M. D. Hall

The paper evaluates inhibitors of mutant IDH1 and IDH2 using biochemical and cell-based assays to identify effective compounds for cancer therapy.

DOI 10.1038/s41598-017-12630-x

humanproteomics

𝕏 PostBluesky